Please login to the form below

Not currently logged in
Email:
Password:

Former AstraZeneca man Graham Walker joins Idea Pharma

Will work with product teams to bridge gap between clinical and commercial

Graham Walker - IDEA PharmaDr Graham Walker has joined product design consultants Idea Pharma as a member of its Ideation team.

He will work alongside global product teams to form strategies for compounds in phase II development in an attempt to link more closely the clinical and commercial stages of a drug's lifespan.

Dr Walker's previous experience in the field includes two years at AstraZeneca between 2009 and 2010 where he served as therapy area physician - oncology.

During his time at the pharma company he was part of the team that helped bring the non small cell lung cancer (NSCLC) drug Iressa (gefitinib) to market.

Dr Walker later left AZ to join Napp Pharmacueuticals in the UK where he worked on the company's respiratory products.

Prior to his career in the industry, Dr Walker served in the clinical environment at several UK hospitals.

He was also director of his own technology company, HealthTrade, from 2001 to 2008, which used the latest technological advancements to provide healthcare solutions.

“My career to date has been built on spearheading innovation within many commercial organisations,” said Dr Walker, “so it makes complete sense to join Idea, a company that is clearly leading the industry in ensuring innovative drugs get to market in great shape. I look forward to tackling the challenges that lie ahead.”

Mike Rea, Idea's CEO, commented: “We were really lucky to find Graham. He was about to accept a great position with one of the 'top 5' when we met.”

14th May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics